Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study will compare the effects of Zoledronic acid and Raloxifene in reducing bone
turnover markers in postmenopausal women with low bone mineral density over 6 months.